Hims & Hers Health Inc. has acquired a California-based manufacturing facility to expand its range of peptide treatments, ...

Generic drugmaker Granules India is foraying into the peptide segment and contract development and manufacturing organisation (CDMO) business with a ₹192.5 crore (CHF 20 million) acquisition of Swiss ...

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

Granules India has purchased Senn Chemicals AG, a Swiss CDMO firm specializing in peptide therapeutics, for CHF 20 million.

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

Kate Farms, the #1 recommended plant-based brand*, is thrilled to introduce a new organic, natural strawberry flavor for ...

A team of microbiologists, chemists and pharmaceutical specialists at Shandong University, Guangzhou Medical University, ...

Many peptide medications like glucagon-like peptide-1 (GLP-1) receptor agonists were initially developed to treat type 2 diabetes. One unexpected side effect of these drugs is weight loss.

Hims & Hers Health, Inc., the leading health and wellness platform, today announced an acquisition that will further verticalize the company’s long-term ability to deliver personalized medications.

Years of sun exposure, stress and the inevitable effects of gravity manage to wreak havoc on our skin in the form of every ...

I left behind dark wads of hair in the shower, sink, bed, and even in my daughter’s mighty little fists. “You gotta stop ...

Hims & Hers Health acquired a peptide facility to strengthen its U.S. supply chain and meet demand for personalized ...